BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 9086436)

  • 1. A high prevalence of functional inactivation by methylation modification of p16INK4A/CDKN2/MTS1 gene in primary urothelial cancers.
    Akao T; Kakehi Y; Itoh N; Ozdemir E; Shimizu T; Tachibana A; Sasaki MS; Yoshida O
    Jpn J Cancer Res; 1997 Nov; 88(11):1078-86. PubMed ID: 9439683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of CDKN2 (CDK4I/MTS1) gene in tissues and cell lines of human prostate cancer.
    Komiya A; Suzuki H; Aida S; Yatani R; Shimazaki J
    Jpn J Cancer Res; 1995 Jul; 86(7):622-5. PubMed ID: 7559077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDKN2 expression is a potential biomarker for T cell exhaustion in hepatocellular carcinoma.
    Wei S; Zhang Y; Kang BE; Park W; Guo H; Nam S; Kang JS; Jeong JH; Jo Y; Ryu D; Jiang Y; Ha KT
    BMB Rep; 2024 Mar; ():. PubMed ID: 38523373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygous Loss of CDKN2 in Primary Cutaneous CD8(+) Lymphoma NOS.
    Robson A; Costa Rosa J; Semkova K; Bakr F; Cabecadas J
    Am J Dermatopathol; 2024 Mar; 46(3):147-152. PubMed ID: 38175704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Unanticipated Modulation of Cyclin-Dependent Kinase Inhibitors: The Role of Long Non-Coding RNAs.
    Bencivenga D; Stampone E; Vastante A; Barahmeh M; Della Ragione F; Borriello A
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Gingerol Inhibits Growth of Colon Cancer Cell LoVo via Induction of G2/M Arrest.
    Lin CB; Lin CC; Tsay GJ
    Evid Based Complement Alternat Med; 2012; 2012():326096. PubMed ID: 22719783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grape seed extract induces cell cycle arrest and apoptosis in human colon carcinoma cells.
    Kaur M; Mandair R; Agarwal R; Agarwal C
    Nutr Cancer; 2008; 60 Suppl 1(Suppl 1):2-11. PubMed ID: 19003575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16(INK4a) gene alterations are frequent in lesions of mycosis fungoides.
    Navas IC; Ortiz-Romero PL; Villuendas R; Martínez P; García C; Gómez E; Rodriguez JL; García D; Vanaclocha F; Iglesias L; Piris MA; Algara P
    Am J Pathol; 2000 May; 156(5):1565-72. PubMed ID: 10793068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of cyclin-dependent kinase 4 inhibitor (p16INK4A/MTS1) gene structure and expression in acute lymphoblastic leukemias.
    Delmer A; Tang R; Senamaud-Beaufort C; Paterlini P; Brechot C; Zittoun R
    Leukemia; 1995 Jul; 9(7):1240-5. PubMed ID: 7630199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDKN2 (MTS1/p16INK4A) gene alterations in hematological malignancies.
    Uchida T; Kinoshita T; Saito H; Hotta T
    Leuk Lymphoma; 1997 Feb; 24(5-6):449-61. PubMed ID: 9086436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16ink4a gene and hematological malignancies.
    Quesnel B; Preudhomme C; Fenaux P
    Leuk Lymphoma; 1996 Jun; 22(1-2):11-24. PubMed ID: 8724524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme.
    Moulton T; Samara G; Chung WY; Yuan L; Desai R; Sisti M; Bruce J; Tycko B
    Am J Pathol; 1995 Mar; 146(3):613-9. PubMed ID: 7887443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukemias and other hematologic malignancies.
    Dreyling MH; Bohlander SK; Le Beau MM; Olopade OI
    Blood; 1995 Sep; 86(5):1931-8. PubMed ID: 7544647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDKN2 (MTS1/p16INK4A) gene alterations in adult T-cell leukemia/lymphoma.
    Uchida T; Kinoshita T; Murate T; Saito H; Hotta T
    Leuk Lymphoma; 1998 Mar; 29(1-2):27-35. PubMed ID: 9638973
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.